The Biotech industry is down 1.5% over the last week with GNI Group the worst performer, down 17%. On the other hand Chordia Therapeutics is actually up 61%. This takes the industry's 12 month performance to a gain of 7.5%. Looking forward, earnings are forecast to grow by 20% annually.
Has the Japanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 26 Jul 2024 | JP¥1.0t | JP¥187.7b | -JP¥15,871,901,000.00 | 92.7x | -65.2x | 5.5x |
Sun, 23 Jun 2024 | JP¥897.9b | JP¥187.7b | -JP¥15,773,284,000.00 | 84.8x | -56.9x | 4.8x |
Tue, 21 May 2024 | JP¥793.5b | JP¥195.9b | -JP¥13,410,545,000.00 | 94.9x | -59.2x | 4.1x |
Thu, 18 Apr 2024 | JP¥732.7b | JP¥194.2b | -JP¥15,746,877,000.00 | 63.7x | -46.5x | 3.8x |
Sat, 16 Mar 2024 | JP¥754.4b | JP¥194.2b | -JP¥18,497,301,000.00 | 57.9x | -40.8x | 3.9x |
Mon, 12 Feb 2024 | JP¥747.3b | JP¥222.8b | -JP¥10,392,827,000.00 | 16.7x | -71.9x | 3.4x |
Wed, 10 Jan 2024 | JP¥818.8b | JP¥222.3b | -JP¥12,668,455,000.00 | 17.6x | -64.6x | 3.7x |
Fri, 08 Dec 2023 | JP¥765.6b | JP¥221.9b | -JP¥12,426,487,000.00 | 16.3x | -61.6x | 3.4x |
Sun, 05 Nov 2023 | JP¥746.6b | JP¥223.0b | -JP¥14,350,085,000.00 | 19.3x | -52x | 3.3x |
Tue, 03 Oct 2023 | JP¥823.8b | JP¥223.0b | -JP¥14,518,735,000.00 | 24.9x | -56.7x | 3.7x |
Thu, 31 Aug 2023 | JP¥925.5b | JP¥225.1b | -JP¥19,814,131,000.00 | 49.8x | -46.7x | 4.1x |
Sat, 29 Jul 2023 | JP¥902.0b | JP¥223.7b | -JP¥20,836,669,000.00 | 49.1x | -43.3x | 4x |
Mon, 26 Jun 2023 | JP¥973.0b | JP¥223.2b | -JP¥20,139,670,000.00 | 64.6x | -48.3x | 4.4x |
Wed, 24 May 2023 | JP¥930.9b | JP¥218.4b | -JP¥25,404,669,000.00 | 32.6x | -36.6x | 4.3x |
Fri, 21 Apr 2023 | JP¥938.3b | JP¥218.1b | -JP¥20,115,522,000.00 | 21.4x | -46.6x | 4.3x |
Sun, 19 Mar 2023 | JP¥935.3b | JP¥218.3b | -JP¥21,582,580,000.00 | 20.9x | -43.3x | 4.3x |
Tue, 14 Feb 2023 | JP¥961.8b | JP¥200.4b | -JP¥25,348,917,000.00 | 38x | -37.9x | 4.8x |
Thu, 12 Jan 2023 | JP¥918.5b | JP¥186.8b | -JP¥24,722,604,000.00 | 40.7x | -37.2x | 4.9x |
Sat, 10 Dec 2022 | JP¥903.5b | JP¥186.6b | -JP¥26,666,433,000.00 | 45.1x | -33.9x | 4.8x |
Mon, 07 Nov 2022 | JP¥813.4b | JP¥176.5b | -JP¥24,630,270,000.00 | 46.8x | -33x | 4.6x |
Wed, 05 Oct 2022 | JP¥875.3b | JP¥176.5b | -JP¥24,974,270,000.00 | 43.2x | -35x | 5x |
Fri, 02 Sep 2022 | JP¥931.7b | JP¥174.4b | -JP¥21,144,270,000.00 | 21.2x | -44.1x | 5.3x |
Sun, 31 Jul 2022 | JP¥980.3b | JP¥171.3b | -JP¥16,252,562,000.00 | 21.2x | -60.3x | 5.7x |
Tue, 28 Jun 2022 | JP¥884.9b | JP¥171.3b | -JP¥16,112,943,000.00 | 20.6x | -54.9x | 5.2x |
Thu, 26 May 2022 | JP¥873.9b | JP¥169.3b | -JP¥13,461,721,000.00 | 10.9x | -64.9x | 5.2x |
Sat, 23 Apr 2022 | JP¥1.0t | JP¥164.2b | -JP¥13,043,295,000.00 | 14.3x | -76.7x | 6.1x |
Mon, 21 Mar 2022 | JP¥1.1t | JP¥164.2b | -JP¥13,044,654,000.00 | 15.2x | -82.4x | 6.5x |
Wed, 16 Feb 2022 | JP¥1.1t | JP¥160.0b | -JP¥6,984,120,000.00 | 15.4x | -153.9x | 6.7x |
Fri, 14 Jan 2022 | JP¥1.2t | JP¥163.5b | -JP¥5,447,358,000.00 | 18x | -218.2x | 7.3x |
Sun, 12 Dec 2021 | JP¥1.2t | JP¥163.7b | -JP¥6,105,358,000.00 | 18.3x | -203x | 7.6x |
Tue, 09 Nov 2021 | JP¥1.3t | JP¥148.1b | -JP¥15,446,127,000.00 | 23.9x | -85.9x | 9x |
Thu, 07 Oct 2021 | JP¥1.4t | JP¥147.6b | -JP¥12,269,440,000.00 | 23x | -115.2x | 9.6x |
Sat, 04 Sep 2021 | JP¥1.7t | JP¥148.3b | -JP¥14,096,440,000.00 | 25.9x | -120x | 11.4x |
Mon, 02 Aug 2021 | JP¥1.6t | JP¥148.3b | -JP¥14,096,440,000.00 | 22.1x | -117x | 11.1x |
-117x
How does Japanese Biotech compare with similar industries?
JP Market | -5.18% | |
Healthcare | -2.00% | |
Biotech | -8.09% | |
Biotech | -8.09% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
190A Chordia Therapeutics | JP¥715.00 | 44.4% +JP¥14.5b | n/a | n/a | |
4563 AnGes | JP¥55.00 | 17.0% +JP¥1.8b | -45.0% | PS50.6x | |
4882 Perseus Proteomics | JP¥684.00 | 18.8% +JP¥1.5b | 148.7% | PS93.5x | |
4597 Solasia Pharma K.K | JP¥41.00 | 17.1% +JP¥1.2b | -8.9% | PS20.7x | |
4883 Modalis Therapeutics | JP¥95.00 | 30.1% +JP¥971.3m | -56.2% | PB3.7x |